An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of and other STH infections. ALIVE trial protocol.

Journal: Gates open research

Publication Year: 

Authors & Co-authors:  Krolewiecki Enbiale Gandasegui van Lieshout Kepha Messa Junior Bengtson Gelaye Escola Martinez-Valladares